The clinical-stage biotech company that develops stem cell treatments posted revenue of $15.9 million in the period, which beat Street forecasts.
News
- Fate Therapeutics: 4Q Earnings Snapshot
- Adaptive Biotechnologies: 4Q Earnings Snapshot
In the final minutes of trading on Wednesday, shares hit $58.39, a rise of 89% in the last 12 months. Most Popular. Photos: San Antonio man selling ...
- The Latest: S. Korean-made vaccines roll off production line
... city of Andong, where local pharmaceutical company SK Bioscience manufactures vaccines developed by AstraZeneca and the University of Oxford.
- Ban on abortion coverage through exchange plans repealed
W. Bruce Vogel, an associate professor in the Department of Health Outcomes and Biomedical Informatics at the University of Florida, specializes in ...
- Bluebird: 4Q Earnings Snapshot
The biotechnology company posted revenue of $10.7 million in the period, which missed Street forecasts. Eleven analysts surveyed by Zacks ...